Skip to content
Home/Companies/Biotech/Trishula Therapeutics
TT

Trishula Therapeutics

Biotech·US·Active·6yr hold

Trishula Therapeutics is a biotech company, headquartered in US.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns Trishula Therapeutics?

Trishula Therapeutics is currently owned by Abingworth through Abingworth Bioventures VII (2018 vintage), since 2020.

Hand-verified · updated 2026-06-10

Abingworth
Investor
Abingworth
Abingworth Bioventures VII · 2018 · Life Sciences VC

Key facts

HQUS
SectorBiotech
StatusActive

More from Abingworth Bioventures VII

Other portfolio companies in the same fund.

Adicet Bio
Active
BiotechUS· 2021
Soteria Biotherapeutics
Active
HealthcareUS· 2021
Atsena Therapeutics
Active
BiotechUS· 2020
Orbus Therapeutics
Active
HealthcareUS· 2020
Q32 Bio
Active
BiotechUS· 2020
Scorpion Therapeutics
Active
BiotechUS· 2020

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings